<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Ischemic stroke in children: Clinical presentation, evaluation, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Ischemic stroke in children: Clinical presentation, evaluation, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Ischemic stroke in children: Clinical presentation, evaluation, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Christine Fox, MD, MAS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sabrina E Smith, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Scott E Kasner, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Douglas R Nordli, Jr, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John F Dashe, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 21, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         While more common in older adults, stroke also occurs in neonates, infants, children, and young adults, resulting in significant morbidity and mortality.
        </p>
        <p>
         An overview of the presentation, evaluation, and diagnosis of arterial ischemic stroke in children one month of age or older is provided here.
        </p>
        <p>
         Other aspects of ischemic stroke in children and young adults are reviewed elsewhere:
        </p>
        <p>
         <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">
          Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors
         </a>
         <br/>
         <a class="medical medical_review" href="/z/d/html/6215.html" rel="external">
          Ischemic stroke in children: Management and prognosis
         </a>
         <br/>
         <a class="medical medical_review" href="/z/d/html/107995.html" rel="external">
          Hemorrhagic stroke in children
         </a>
         <br/>
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          Cerebral venous thrombosis: Etiology, clinical features, and diagnosis
         </a>
         <br/>
         <a class="medical medical_review" href="/z/d/html/6157.html" rel="external">
          Stroke in the newborn: Classification, manifestations, and diagnosis
         </a>
        </p>
        <p class="headingAnchor" id="H2119402945">
         <span class="h1">
          CLINICAL PRESENTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants and young children with stroke may present with focal weakness, but are more likely than older children to present with seizures and altered mental status [
         <a href="#rid1">
          1,2
         </a>
         ]. Older children usually have hemiparesis or other focal neurologic signs such as aphasia, visual disturbance, or cerebellar signs, although seizures, headache, and lethargy are more common among children than adults [
         <a href="#rid3">
          3-7
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Focal manifestations
         </strong>
         – In various reports, the frequency of focal neurologic manifestations with acute stroke in children include the following [
         <a href="#rid2">
          2,7
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hemiparesis and hemifacial weakness in 67 to 90 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Speech or language disturbance in 20 to 50 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Visual disturbance in 10 to 15 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ataxia in 8 to 10 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonlocalizing manifestations
         </strong>
         – The most frequent nonlocalizing manifestations in arterial ischemic stroke are the following [
         <a href="#rid2">
          2,7
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Headache in 20 to 50 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Altered mental status in 17 to 38 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vomiting in approximately 10 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seizures
         </strong>
         – Seizures at stroke onset occur in 15 to 25 percent of children with arterial ischemic stroke; the frequency is highest in younger children, particularly those less than six years of age [
         <a href="#rid2">
          2,4,7
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Certain presentations may be associated with mechanism or localization:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac etiology
         </strong>
         – Arterial ischemic stroke caused by cardiac disease tends to occur predominantly among younger children (median age six months to three years) with complex congenital heart disease and is associated with a relatively high frequency of seizures (up to 40 percent) and bilateral strokes in the anterior and posterior circulation, and a tendency to hemorrhagic transformation of ischemic infarcts [
         <a href="#rid8">
          8-11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Posterior circulation infarcts
         </strong>
         – In children, most posterior circulation infarcts (63 to 77 percent) occur in boys for reasons that are unknown [
         <a href="#rid7">
          7,12-15
         </a>
         ]. Common presenting manifestations of posterior circulation infarcts in children include hemiparesis, ataxia, dysarthria, visual field deficits, and oculomotor involvement [
         <a href="#rid7">
          7,13,15
         </a>
         ]. Frequent nonlocalizing symptoms include headache, vomiting, and altered mental status. Common causes include vertebral artery dissection, often with a history of recent head or neck trauma, and cardioembolic stroke [
         <a href="#rid7">
          7,12,15,16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          URGENT EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H2050495754">
         <span class="h2">
          Goals of initial evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Urgent evaluation and neuroimaging is important for confirming the diagnosis of acute arterial ischemic stroke  (
         <a class="graphic graphic_algorithm graphicRef103189" href="/z/d/graphic/103189.html" rel="external">
          algorithm 1
         </a>
         ) and excluding stroke mimics; numerous conditions can mimic ischemic stroke, particularly with regard to children, including but not limited to migraine, seizure with Todd paralysis, Bell's palsy, and infection [
         <a href="#rid17">
          17,18
         </a>
         ]. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
         The diagnosis of stroke is often delayed or initially misdiagnosed in children [
         <a href="#rid19">
          19,20
         </a>
         ]. In a retrospective series of 209 children (one month to 18 years old) who presented with acute arterial ischemic stroke, the mean interval from symptom onset to diagnosis was 22.7 hours [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
         The urgent evaluation proceeds in tandem with consideration of immediate interventions – once the diagnosis of ischemic stroke is confirmed – that may improve stroke outcome  (
         <a class="graphic graphic_algorithm graphicRef103189" href="/z/d/graphic/103189.html" rel="external">
          algorithm 1
         </a>
         ), including possible hyperacute reperfusion therapies with intravenous thrombolysis (within 4.5 hours of the time the patient was last seen well) and mechanical thrombectomy (within 24 hours of last seen well).
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Brain imaging
         </span>
        </p>
        <p class="headingAnchor" id="H2157029923">
         <span class="h3">
          Choice of imaging study
         </span>
         <span class="headingEndMark">
          —
         </span>
         We obtain a brain magnetic resonance imaging (MRI) with diffusion weighted imaging and vascular imaging with magnetic resonance angiography (MRA) as the initial studies, which should be obtained as soon as possible in children who present with suspected ischemic stroke. Head computed tomography (CT) is generally considered inadequate to diagnose ischemic stroke in children, and MRI may be required to reliably exclude stroke mimics [
         <a href="#rid17">
          17,22-27
         </a>
         ].
        </p>
        <p>
         Brain MRI is more sensitive for acute ischemia than CT, particularly with use of diffusion-weighted imaging in the hyperacute time period. In addition, brain MRI provides better visualization of the posterior fossa. Head CT with CT angiography (CTA) should be obtained if MRI/MRA is not tolerated or will not be available within one hour after arrival. For children with complex congenital heart disease, CT/CTA may be used as the initial imaging study if determination of cardiac hardware compatibility with MRI would entail significant delay. In young adults, either CT or MRI may be used as the initial study, but we prefer brain MRI with diffusion-weighted imaging (DWI) if available because it is more sensitive for the diagnosis of acute stroke than CT.
        </p>
        <p>
         Availability of urgent neuroimaging of children is a challenge and may influence clinical algorithms for suspected stroke in a child. Australian guidelines recommend MRI as the diagnostic imaging modality of choice for suspected arterial ischemic stroke, but CT imaging including CTA and CT perfusion can be considered as an alternative where urgent MRI is not possible [
         <a href="#rid28">
          28
         </a>
         ]. UK guidelines recommend cranial CT, including CTA, within one hour of arrival at hospital for every child with suspected stroke; they note that brain MRI can be used as the initial study if it is available within one hour of arrival [
         <a href="#rid22">
          22
         </a>
         ]. The guidelines also recommend that brain MRI, including MRA, should be obtained within 24 hours if the initial head CT is negative and stroke is still suspected.
        </p>
        <p class="headingAnchor" id="H2575692724">
         <span class="h3">
          MRI appearance of ischemic stroke
         </span>
         <span class="headingEndMark">
          —
         </span>
         On brain MRI, acute stroke is associated with restricted diffusion in an arterial territory on DWI, just as in older adults. This can persist for 7 to 14 days after stroke onset, at which time restricted diffusion transitions to increased diffusion. Subacute stroke is associated with increased T2-weighted signal and enhancement with gadolinium. Chronic stroke is associated with increased diffusion, increased T2 signal, and evidence of volume loss, including ex vacuo dilatation of the lateral ventricles or porencephaly. Gradient echo imaging is sensitive to the presence of blood products. (See
         <a class="medical medical_review" href="/z/d/html/1085.html" rel="external">
          "Neuroimaging of acute stroke", section on 'Assessment of early infarct signs'
         </a>
         .)
        </p>
        <p>
         MRI with gadolinium contrast may be helpful in identifying conditions that can mimic stroke clinically, but gadolinium is not necessary for the diagnosis of ischemic stroke.
        </p>
        <p class="headingAnchor" id="H1472554309">
         <span class="h3">
          CT appearance of ischemic stroke
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early infarct signs, such as cortical effacement with loss of gray-white differentiation, loss of the insular ribbon, and hyperdense artery sign, may be observed on noncontrast head CT acutely, and within 24 hours hypodensity in an arterial territory may be appreciated. (See
         <a class="medical medical_review" href="/z/d/html/1085.html" rel="external">
          "Neuroimaging of acute stroke", section on 'Assessment of early infarct signs'
         </a>
         .)
        </p>
        <p>
         Data from a prospectively identified cohort of 63 children with acute arterial ischemic stroke suggest that hemorrhagic transformation is observed in approximately 30 percent of children within one month of stroke onset [
         <a href="#rid29">
          29
         </a>
         ]. In most cases, the hemorrhage is clinically asymptomatic and has a petechial appearance on brain imaging with CT or MRI [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H601624389">
         <span class="h3">
          CT safety considerations
         </span>
         <span class="headingEndMark">
          —
         </span>
         When clinically indicated, CT is considered a relatively safe procedure in children with proper application of radiation protection, appropriate use of nonionic contrast agents, proper administration of sedation or anesthesia when needed, and monitoring of vital signs.
        </p>
        <p>
         Relative contraindications to CT in children are unusual but include certain syndromes in which radiation could induce chromosome breaks and increase the genetic predisposition to tumors (eg, ataxia telangiectasia, Nijmegen breakage syndrome) [
         <a href="#rid31">
          31-37
         </a>
         ]. However, such studies should not be withheld if they are required to provide optimal management. (See
         <a class="medical medical_review" href="/z/d/html/6233.html" rel="external">
          "Ataxia-telangiectasia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3957.html" rel="external">
          "Nijmegen breakage syndrome"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Radiation dose
         </strong>
         – Radiation dose is particularly important in children because radiation exposure from CT scanning appears to be associated with a small increased lifetime risk of cancer, including central nervous system tumors [
         <a href="#rid38">
          38-41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, there is some evidence that early radiation to the brain may impair long-term cognitive function [
         <a href="#rid42">
          42,43
         </a>
         ]. Although pediatric CT accounts for approximately 15 percent of radiographic examinations, it contributes to an estimated 70 percent of the total radiation dose to the population [
         <a href="#rid44">
          44,45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Minimizing radiation exposure
         </strong>
         – Every effort must be made to minimize the radiation dose to children from CT examinations. The policy of "as low as reasonably achievable" (ALARA), or "least radiation dose necessary" to produce a diagnostic scan should always be followed [
         <a href="#rid46">
          46,47
         </a>
         ]. This concept employs the following methods:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Use weight-based protocols and improved shielding
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Consider alternative nonradiating imaging modalities, such as MRI
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When clinically appropriate, use focused and/or limited-view studies
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dissuade repeat CT studies
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The Image Gently campaign (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.imagegently.org%2F&amp;token=bJ98wEjwYbR6KcGnbD%2BLoZYdxzvQqx9VmbmqNcayEUKCjtXTC6Y5e9KALMc%2BCxiR&amp;TOPIC_ID=6214" target="_blank">
          www.imagegently.org
         </a>
         ) offers information for practitioners, radiology technicians, and parents regarding opportunities to use lower radiation doses in the imaging of children [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2287303647">
         <span class="h2">
          Vessel imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to brain imaging, a neurovascular evaluation should be done urgently, particularly if the child is a candidate for reperfusion with thrombolysis or mechanical thrombectomy. We suggest MRA of the neck and head (three-dimensional time-of-flight) without and with contrast enhancement to evaluate the extracranial and intracranial large arteries. CTA can be substituted depending on availability and local expertise, but MRA is preferred because CTA incurs the hazards of radiation and contrast exposure [
         <a href="#rid7">
          7
         </a>
         ]. Cerebrovascular imaging with CTA or MRA should cover the aortic arch to the vertex (ie, the extracranial and intracranial cerebral vessels) [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H445976944">
         <span class="h2">
          Triage for hyperacute reperfusion therapies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperacute reperfusion therapies may be appropriate for selected children with arterial ischemic stroke. Older children and adolescents within 6 hours of ischemic stroke onset who have a causative large artery occlusion on CTA or MRA may be eligible for mechanical thrombectomy if neuroimaging is consistent with a small infarct core (ie, there are limited signs of early ischemic change on diffusion-weighted MRI or CT without contrast). Mechanical thrombectomy may still be an option for selected children presenting within 6 to 24 hours of stroke onset who meet the eligibility criteria used in adults, other than age  (
         <a class="graphic graphic_algorithm graphicRef141874" href="/z/d/graphic/141874.html" rel="external">
          algorithm 2
         </a>
         ). However, thresholds for estimating core infarct versus penumbra using processed perfusion imaging may differ in young patients compared with older adults, and thresholds for benefit in children have not been established [
         <a href="#rid49">
          49
         </a>
         ]. Young patients with good pial collaterals may transiently present with smaller perfusion deficits despite a large artery occlusion. In healthy children without stroke, typical values for quantitative perfusion studies change with age and brain maturity [
         <a href="#rid50">
          50
         </a>
         ]. Selection for mechanical thrombectomy in the extended time window should be done in consultation with neurologists and neuro-interventionalists who have expertise in treating children with stroke.
        </p>
        <p>
         Reperfusion therapies are reviewed in greater detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6215.html" rel="external">
          "Ischemic stroke in children: Management and prognosis", section on 'Reperfusion with thrombolysis and thrombectomy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/115663.html" rel="external">
          "Mechanical thrombectomy for acute ischemic stroke"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Laboratory studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         The initial evaluation for stroke in children should include the following studies [
         <a href="#rid22">
          22,23
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complete blood count including platelets
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Electrolytes, urea nitrogen, creatinine
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum glucose
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prothrombin time (PT) and international normalized ratio (INR)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Partial thromboplastin time (PTT)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oxygen saturation
        </p>
        <p>
        </p>
        <p>
         In selected patients, particularly those with a confirmed diagnosis of arterial ischemic stroke, additional studies may be useful [
         <a href="#rid22">
          22,23
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lumbar puncture if there is suspicion for an infectious etiology of stroke
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Electroencephalogram if seizures are suspected (eg, involuntary movements)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hemoglobin electrophoresis in patients with possible sickle cell disease (eg, if suggested by personal or family history)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Toxicology screen if etiology remains unclear
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pregnancy test in girls of childbearing potential
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thrombin time and/or ecarin clotting time for rare pediatric patients who might be taking a direct thrombin inhibitor or a direct factor Xa inhibitor
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2069679657">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of ischemic stroke is broad, as numerous other conditions can present with acute neurologic deficits. In addition, the differential is further extended in young children because stroke may present with nonspecific signs such as seizures or lethargy.
        </p>
        <p>
         Hemorrhagic stroke can mimic ischemic stroke and is best differentiated by neuroimaging.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intracranial hemorrhage
         </strong>
         (due in most cases to vascular malformation or hematologic abnormalities) can present much like arterial ischemic stroke. Hemorrhagic stroke is differentiated from ischemic stroke by imaging with cranial magnetic resonance imaging (MRI) or noncontrast computed tomography (CT) scan. MRI with gradient echo and/or susceptibility-weighted sequences is equally sensitive to CT for acute parenchymal hemorrhage. (See
         <a class="medical medical_review" href="/z/d/html/107995.html" rel="external">
          "Hemorrhagic stroke in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Lumbar puncture is indicated if there is clinical suspicion for subarachnoid hemorrhage (eg, severe or sudden-onset headache) and CT or MRI scan is negative for blood. (See
         <a class="medical medical_review" href="/z/d/html/1130.html" rel="external">
          "Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis", section on 'Need for lumbar puncture when early CT is negative'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cerebral venous sinus thrombosis
         </strong>
         is highly variable in presentation. The onset can be acute, subacute, or chronic. Headache is the most frequent symptom and may occur as part of an isolated intracranial hypertension syndrome, with or without vomiting, papilledema, and visual problems. In other cases, headache may be accompanied by focal neurologic deficits, focal or generalized seizures, and encephalopathy. The combination of an abnormal signal in a venous sinus on brain MRI and the corresponding absence of flow on magnetic resonance (MR) venography confirms the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seizure with postictal paresis (Todd paralysis)
         </strong>
         can mimic stroke, particularly when the seizure itself is very brief, unwitnessed, or occurs during sleep. Manifestations of the postictal period typically include confusion and suppressed alertness. Postictal paresis often involves weakness of a hand, arm, or leg that appears following a focal motor seizure involving the one side of the body. The degree of weakness is usually moderate but can be severe. Other focal postictal symptoms vary according to the location of the seizure and may include aphasia, hemianopsia, or numbness. Although there is a broad range, most patients begin to recover responsiveness and alertness within 10 to 20 minutes of a generalized seizure and show gradual, consistent improvement in postictal symptoms as time elapses. Neuroimaging with MRI is helpful to evaluate for acute stroke and for structural abnormalities that cause seizures; electroencephalography (EEG) and lumbar puncture, as clinically indicated. (See
         <a class="medical medical_review" href="/z/d/html/6218.html" rel="external">
          "Seizures and epilepsy in children: Clinical and laboratory diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Migraine
         </strong>
         can be confused with stroke and other causes of acute neurologic symptoms, particularly in the setting of the emergency department, where children may be more likely to present with a first episode of moderate to severe headache. Migraine aura, when it occurs, is most often visual and gradually progressive. By contrast, stroke typically has a sudden onset of symptoms rather than a gradual progressive spread of one aura symptom after another. Ischemic events are less likely to have positive symptoms such as visual scintillations or paresthesia and are less likely to have migrainous symptoms such as nausea, vomiting, photophobia, and phonophobia. Unlike stroke, the symptoms of migraine are fully reversible, and neuroimaging is typically unrevealing. (See
         <a class="medical medical_review" href="/z/d/html/6161.html" rel="external">
          "Pathophysiology, clinical features, and diagnosis of migraine in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Hemiplegic migraine is rare; it is distinguished from other types of migraine with aura by the presence of motor weakness as a manifestation of aura in at least some attacks. (See
         <a class="medical medical_review" href="/z/d/html/14112.html" rel="external">
          "Hemiplegic migraine"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bell's palsy
         </strong>
         can mimic stroke with onset of unilateral facial paralysis, typically over hours. Common findings include diffuse involvement of all of the distal branches of the facial nerve, with sagging of the eyebrow and inability to close the eye. Decreased tearing, hyperacusis, and/or loss of taste sensation on the anterior two-thirds of the tongue may also occur. These features help to distinguish Bell's palsy (a peripheral nerve lesion) from stroke (a central lesion), which normally spares the forehead muscles and does not affect tearing, taste sensation, or hearing. (See
         <a class="medical medical_review" href="/z/d/html/6217.html" rel="external">
          "Facial nerve palsy in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Alternating hemiplegia of childhood
         </strong>
         (AHC) is a rare genetic condition characterized by periodic episodes of hemiplegia or quadriplegia [
         <a href="#rid51">
          51
         </a>
         ]. Onset in infancy, recurrent episodes, and associated symptoms (dystonia, paroxysmal eye movements, seizures, cognitive impairment, and ataxia) help to distinguish it from stroke.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Brain tumors
         </strong>
         in children may present with nonspecific signs and symptoms that occur commonly in children (eg, headache, nausea and vomiting, developmental and behavioral problems) and symptoms that are more suggestive of central nervous system pathology (eg, ataxia, cranial nerve palsies, impaired vision, seizures, papilledema, macrocephaly). The diagnosis of a brain tumor is based upon identification of the lesion by neuroimaging, preferably by MRI, or CT if MRI is not an option. (See
         <a class="medical medical_review" href="/z/d/html/6250.html" rel="external">
          "Clinical manifestations and diagnosis of central nervous system tumors in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Central nervous system infection
         </strong>
         (meningitis, encephalitis, abscess) can cause headache and hemiparesis, but clinical signs (eg, rash, fever, nuchal rigidity), cerebrospinal fluid (CSF) analysis (eg, pleocytosis), and neuroimaging findings (eg, meningeal enhancement or parenchymal lesion) usually point to the correct diagnosis. In some cases, however, infection can trigger stroke from a variety of etiologies, and meningitis can cause an infectious arteritis of vessels in the subarachnoid space, which in turn may result in thrombosis, ischemia, and infarction. (See
         <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">
          "Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors", section on 'Infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">
          "Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors", section on 'Diffuse vasculitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Posterior reversible encephalopathy syndrome
         </strong>
         (PRES; also called reversible posterior leukoencephalopathy syndrome) is a neurologic syndrome that most often presents with headache, confusion, visual symptoms, and seizures. Typical MRI findings are consistent with vasogenic edema in the subcortical white matter and are predominantly localized to the posterior cerebral hemispheres. The differentiation of vasogenic versus cytotoxic edema with diffusion-weighted MRI is helpful in distinguishing reversible posterior leukoencephalopathy syndrome from stroke. (See
         <a class="medical medical_review" href="/z/d/html/4835.html" rel="external">
          "Reversible posterior leukoencephalopathy syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute disseminated encephalomyelitis
         </strong>
         (ADEM) is a demyelinating disease of the central nervous system that typically presents as a monophasic disorder associated with multifocal neurologic symptoms and encephalopathy. ADEM is preceded by a viral or bacterial infection in approximately 75 percent of cases. Unlike stroke, brain MRI in ADEM typically shows diffuse, poorly demarcated, large (&gt;1 to 2 cm) lesions predominantly involving the white matter. (See
         <a class="medical medical_review" href="/z/d/html/6184.html" rel="external">
          "Acute disseminated encephalomyelitis (ADEM) in children: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Idiopathic intracranial hypertension
         </strong>
         typically presents in obese woman of childbearing age with headaches and papilledema, though it can occur in children. Other common features are transient visual obscurations, pulsatile tinnitus, and diplopia. MRI with and without contrast including postcontrast MR venography is the preferred imaging study; suggestive findings for the diagnosis include empty sella, flattening of the posterior aspect of the globe, distension of the perioptic subarachnoid space, and transverse venous sinus stenosis. (See
         <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">
          "Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute cerebellar ataxia
         </strong>
         in children is a clinical syndrome characterized by the sudden onset of ataxia, usually manifested as gait disturbance; associated symptoms may include nystagmus, slurred or garbled speech, vomiting, irritability, dysarthria, or headache. Fever, meningismus, and seizures are absent. Most cases occur in toddlers or school-aged children; in many cases the symptoms develop a few days or weeks after a viral illness. CSF analysis in acute cerebellar ataxia is typically normal or shows a mild lymphocytic pleocytosis, with or without elevations in protein. Neuroimaging is not necessary for children with typical features. (See
         <a class="medical medical_review" href="/z/d/html/6206.html" rel="external">
          "Acute cerebellar ataxia in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Other nonvascular conditions that may mimic stroke in children include drug toxicity, musculoskeletal conditions, and psychogenic disorders [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2472549286">
         <span class="h1">
          EVALUATION FOR ETIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H1911045588">
         <span class="h2">
          Essential evaluation for all patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation of children with arterial ischemic stroke should screen for the most common causes, including imaging of intracranial and extracranial cerebral arteries (if not already done as part of the urgent evaluation), assessment of heart structure and function, and hypercoagulable testing [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         Stroke in children is a multifactorial disease, and the presence of multiple risk factors for stroke increases recurrence risk [
         <a href="#rid52">
          52
         </a>
         ], so the full diagnostic evaluation should be completed even if one risk factor is identified. In support of this, a case-control study of 38 children with underlying cardiac disease and ischemic stroke found more than one hemostatic abnormality consistent with a prothrombotic state in 11 percent of cases and in none of the 100 age-matched controls [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         For all children with a diagnosis of arterial ischemic stroke, United Kingdom guidelines from the Royal College of Paediatrics and Child Health (RCPCH) recommend evaluation for a history of prior infection (especially varicella zoster virus), immunization, dysmorphic features, neurocutaneous stigmata, autoimmune disease, and evidence of vascular disease in other organ systems [
         <a href="#rid22">
          22
         </a>
         ]. These evaluations are useful in the work-up for focal cerebral arteriopathy (see
         <a class="local">
          'Focal cerebral arteriopathy'
         </a>
         below) and for some less common underlying causes of stroke (see
         <a class="local">
          'Rare causes of stroke'
         </a>
         below), including
         <em>
          ACTA2
         </em>
         mutations and other genetic diseases.
        </p>
        <p class="headingAnchor" id="H355013898">
         <span class="h2">
          Cardiac evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with arterial ischemic stroke should have a cardiac evaluation including electrocardiogram with inpatient cardiac monitoring, and transthoracic echocardiography (TTE) with agitated
         <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">
          saline
         </a>
         study to evaluate for possible cardiac source of embolism, including right to left shunt. The most common cardiac causes of stroke are cardiac anomalies (congenital or acquired) and arrhythmia. (See
         <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">
          "Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors", section on 'Cardiac'
         </a>
         .)
        </p>
        <p>
         The role of patent foramen ovale (PFO) as a cause of stroke in childhood is not settled. Nevertheless, some experts advise four-extremity Doppler ultrasound in children with cryptogenic stroke who have a positive bubble study on TTE [
         <a href="#rid7">
          7
         </a>
         ]. Others advise consideration of transesophageal echocardiography (TEE) if TTE is nondiagnostic, or if there is a high index of suspicion for a cardioembolic source.
        </p>
        <p>
         Cardiac enzymes and troponin should be obtained if there is clinical suspicion of myocardial ischemia [
         <a href="#rid22">
          22,23
         </a>
         ]. Patients at heightened risk for myocardial ischemia include those with known congenital heart disease, heart transplant, substance abuse, or prior Kawasaki disease. Clinical features suggesting myocardial ischemia include the presence of chest pain and abnormalities on cardiac examination or electrocardiogram (ECG).
        </p>
        <p>
         The management of acute ischemic stroke due to cardiogenic embolism is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6215.html" rel="external">
          "Ischemic stroke in children: Management and prognosis", section on 'Cardioembolic source'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H198752772">
         <span class="h2">
          Arteriopathy evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         As noted above (see
         <a class="local">
          'Vessel imaging'
         </a>
         above), the preferred vessel imaging modality for arteriopathy is magnetic resonance angiography (MRA) of the neck and head (three-dimensional time-of-flight) without and with contrast enhancement of the extracranial and intracranial large arteries. Computed tomography angiography (CTA) can be substituted depending on availability and local expertise, but MRA is preferred because CTA incurs the hazards of radiation and contrast exposure [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         Important etiologic considerations in the evaluation for arteriopathy are extracranial dissection, focal cerebral arteriopathy (including inflammatory and intracranial dissection subtypes), moyamoya, and Takayasu arteritis [
         <a href="#rid7">
          7
         </a>
         ]. Neck pain can be associated with cervical artery dissection, and a Horner syndrome may accompany carotid dissection. (See
         <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">
          "Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors", section on 'Arteriopathy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1131.html" rel="external">
          "Moyamoya disease and moyamoya syndrome: Etiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8238.html" rel="external">
          "Clinical features and diagnosis of Takayasu arteritis"
         </a>
         .)
        </p>
        <p>
         A segmental banding pattern  (
         <a class="graphic graphic_diagnosticimage graphicRef121463" href="/z/d/graphic/121463.html" rel="external">
          image 1
         </a>
         ) is considered a pathognomonic feature of focal cerebral arteriopathy-inflammatory type (FCA-i), but is only present in a minority of cases [
         <a href="#rid54">
          54
         </a>
         ]. Magnetic resonance imaging (MRI) with arterial wall imaging is useful when an inflammatory arteriopathy or intracranial dissection is suspected. Axial T1 MRI of the neck with fat saturation increases the likelihood for detecting extracranial dissection [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Treatment for ischemic stroke caused by arteriopathy is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6215.html" rel="external">
          "Ischemic stroke in children: Management and prognosis", section on 'Arteriopathy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1116177205">
         <span class="h3">
          Arterial wall imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Where available at centers with sufficient expertise, MRI with arterial wall imaging is valuable because it can detect nonstenotic lesions that are not apparent on angiography using MRA, CTA, or DSA; arterial wall imaging can further characterize stenotic lesions that have already been visualized using angiography [
         <a href="#rid55">
          55,56
         </a>
         ]. Arterial wall imaging can help differentiate between various types of intracranial arterial lesions, including vasculitis, arterial dissection, moyamoya, and other causes of intracranial arterial narrowing.
        </p>
        <p>
         The MRI techniques to visualize thin intracranial arterial walls require high contrast-to-noise and high spatial resolution, which are best achieved with a minimum magnetic field strength of 3 Tesla. In addition, arterial wall visualization requires suppression of signal in luminal blood and cerebrospinal fluid ("black-blood" sequences). MRI protocols vary among centers; one technique for arterial wall imaging involves high-resolution, two-dimensional T1-weighted fluid-attenuated inversion recovery (FLAIR) fast spin echo sequences before and after intravenous gadolinium contrast [
         <a href="#rid26">
          26,57
         </a>
         ]. Arterial wall imaging should focus on the abnormal vessel detected by angiography (if present) that supplies the location of acute brain infarct, or, if there is no abnormality on angiography, on the major artery supplying the vascular territory of the infarct.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Hypercoagulable evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Numerous prothrombotic conditions are risk factors for ischemic stroke in children. We suggest the following studies as part of the evaluation for a hypercoagulable state in children with arterial ischemic stroke:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protein C functional
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protein S free and total or protein S functional
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antithrombin activity
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lipoprotein (a)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prothrombin G20210A variant
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Factor V Leiden
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antiphospholipid antibody panel
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Factor VIII activity
        </p>
        <p>
        </p>
        <p>
         We screen for a hypercoagulable state in most children with ischemic stroke except those with sickle cell disease. In our clinical experience, this approach is especially important for children with congenital heart disease. These children undergo frequent instrumentation and line placement. While the cardiac defect is a strong risk factor for stroke, identification of a prothrombotic abnormality that may be a second risk factor for stroke can influence management. As an example, anticoagulation may be instituted in children with congenital heart disease and a prothrombotic state to prevent clot formation and possible stroke during high-risk periods.
        </p>
        <p>
         However, the evidence supporting this approach is limited, and the precise role of prothrombotic states in stroke pathophysiology remains unclear. The American Heart Association/American Stroke Association (AHA/ASA) scientific statement notes that an evaluation for thrombophilia is helpful in every case of childhood stroke, yet may not be clinically indicated if there is an alternative explanation for the stroke [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5920.html" rel="external">
          "Thrombophilia testing in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">
          "Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors", section on 'Hematologic'
         </a>
         .)
        </p>
        <p>
         Note that antiphospholipid antibodies (ie, lupus anticoagulant, anticardiolipin antibodies, and beta2-glycoprotein I antibodies) may be positive after viral infections or acute stroke [
         <a href="#rid7">
          7,58
         </a>
         ]. Therefore, testing should be repeated 12 weeks after a positive test performed immediately after an acute stroke in order to determine whether antiphospholipid antibody syndrome is the underlying condition. (See
         <a class="medical medical_review" href="/z/d/html/4678.html" rel="external">
          "Diagnosis of antiphospholipid syndrome"
         </a>
         .)
        </p>
        <p>
         The management of children with arterial stroke due to a confirmed hypercoagulable state is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6215.html" rel="external">
          "Ischemic stroke in children: Management and prognosis", section on 'Hypercoagulable state'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H586963713">
         <span class="h1">
          ADDITIONAL EVALUATION FOR SELECTED PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Additional studies may be indicated for children with certain findings – or no identified cause – of arterial ischemic stroke.
        </p>
        <p class="headingAnchor" id="H3446481946">
         <span class="h2">
          Inflammation evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         For select children with suspicion for an inflammatory cause of arterial ischemic stroke or for those with otherwise unexplained (cryptogenic) stroke, the initial evaluation includes testing for erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) level, and antinuclear antibody (ANA) assay.
        </p>
        <p>
         Repeated testing at one month may be indicated when the cause for stroke is unclear, as persistent elevation of these inflammatory markers beyond one month after stroke onset raises suspicion for inflammatory conditions including primary angiitis of the central nervous system, systemic lupus erythematosus, adenosine deaminase 2 (ADA2) deficiency, and polyarteritis nodosa [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="local">
          'Rare causes of stroke'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4004442878">
         <span class="h2">
          Focal cerebral arteriopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         For children with focal cerebral arteriopathy of uncertain origin, additional studies include the following [
         <a href="#rid7">
          7
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Magnetic resonance imaging (MRI) with arterial wall imaging. (See
         <a class="local">
          'Arterial wall imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Herpes simplex virus (HSV) and varicella zoster virus (VZV) polymerase chain reaction (PCR) and antibodies (immunoglobulin M [IgM] and immunoglobulin G [IgG] antibodies) tested in the blood or cerebrospinal fluid.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Early follow-up vascular imaging (five to seven days after initial imaging) for progressive narrowing or stenosis.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3885419887">
         <span class="h2">
          Diffuse or multifocal cerebral vasculitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diffuse or multifocal vasculitis in children is typically secondary to infection, predominantly from meningitis or other central nervous system (CNS) infections (eg, tuberculous meningitis), and sepsis. Diffuse vasculitis may be secondary to autoimmune disease such as systemic lupus erythematosus. Rarely, it may be due to a primary angiitis of the central nervous system. (See
         <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">
          "Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors", section on 'Diffuse vasculitis'
         </a>
         .)
        </p>
        <p>
         Multifocal vasoconstriction mimicking vasculitis may be seen in cases of reversible cerebral vasoconstriction syndrome (RCVS). (See
         <a class="medical medical_review" href="/z/d/html/14075.html" rel="external">
          "Reversible cerebral vasoconstriction syndrome", section on 'Neurovascular imaging'
         </a>
         .)
        </p>
        <p>
         The following studies are suggested whenever there is clinical suspicion of diffuse vasculitis, inflammation, or infection as the cause of ischemic stroke in children:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         ESR, CRP level, and ANA; although nonspecific, persistent elevation of these markers beyond one month raises suspicion for primary angiitis of the central nervous system, systemic lupus erythematosus, ADA2 deficiency, and polyarteritis nodosa.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerebral digital subtraction angiography, if there is concern for moyamoya syndrome or disease, to confirm the diagnosis and to guide planning for revascularization surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lumbar puncture and cerebrospinal fluid (CSF) examination with cell count, differential, protein concentration, acid-fast bacilli testing, and CSF analysis for herpes simplex virus via PCR and varicella-zoster virus via PCR and IgM and IgG antibodies; in rare adolescents with suspected or known history of HIV infection or neurosyphilis, testing should include determination of the CSF-Venereal Disease Research Laboratory (VDRL) titer. While a reactive CSF-VDRL establishes the diagnosis of neurosyphilis, a nonreactive test does not exclude the diagnosis. Neurosyphilis, if suspected, is also evaluated by serum nontreponemal tests (eg, VDRL or Rapid Plasma Reagin [RPR]) and serum treponemal tests (eg, fluorescent treponemal antibody absorption [FTA-ABS] or
         <em>
          Treponema pallidum
         </em>
         particle agglutination assay [TPPA]). (See
         <a class="medical medical_review" href="/z/d/html/7599.html" rel="external">
          "Neurosyphilis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HIV testing. (See
         <a class="medical medical_review" href="/z/d/html/6006.html" rel="external">
          "Diagnostic testing for HIV infection in infants and children younger than 18 months"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3736.html" rel="external">
          "Screening and diagnostic testing for HIV infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3717.html" rel="external">
          "Acute and early HIV infection: Treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1565448601">
         <span class="h2">
          Multiple posterior circulation infarctions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple acute or sequential posterior circulation infarcts should raise suspicion for vertebral artery dissection or rotational vertebral arteriopathy [
         <a href="#rid7">
          7
         </a>
         ]. Transcranial Doppler ultrasonography and/or vessel imaging with magnetic resonance angiography (MRA) or computed tomography angiography (CTA) may detect arterial irregularity or dissection; axial T1 MRI of the neck with fat saturation increases the likelihood for detecting extracranial dissection [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Rotational vertebral artery syndrome (bow hunter syndrome) is a potential cause of stroke due to pseudoaneurysm and/or dissection involving the V3 segment of the vertebral artery that typically affects boys (see
         <a class="medical medical_review" href="/z/d/html/6213.html" rel="external">
          "Ischemic stroke in children and young adults: Epidemiology, etiology, and risk factors", section on 'Other vascular abnormalities'
         </a>
         ). When bow hunter syndrome is suspected, we obtain a dynamic study using digital subtraction angiography (DSA; catheter angiography with contrast) or CTA of the neck with head turning, which can establish the diagnosis by showing cessation of flow within the VA with rotation. While this procedure is associated with a risk of recurrent posterior circulation ischemia and stroke, we have not observed this complication. When bow hunter syndrome is suspected, we also obtain flexion-extension films of the cervical spine to evaluate for instability or bony anomalies (eg, congenital arcuate foramen).
        </p>
        <p class="headingAnchor" id="H1834955643">
         <span class="h2">
          Rare causes of stroke
         </span>
         <span class="headingEndMark">
          —
         </span>
         Further evaluation for rare causes of stroke is directed by specific clinical findings [
         <a href="#rid7">
          7
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          ADA2 deficiency
         </strong>
         , diagnosed by testing for
         <em>
          CECR1
         </em>
         mutations and plasma ADA2 activity, in cases with elevated inflammatory markers and variable features that may include intermittent fevers, proteinuria, hypertension, peripheral neuropathy, humoral immunodeficiency, and skin disease (ie, livedo reticularis, hand nodules) [
         <a href="#rid59">
          59-61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multisystem smooth muscle dysfunction syndrome
         </strong>
         , diagnosed by testing for
         <em>
          ACTA2
         </em>
         mutations, in cases of straight ectatic internal carotid arteries, aortic disease, congenital mydriasis, hypotonic bladder, and/or pulmonary hypertension [
         <a href="#rid62">
          62,63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fabry disease
         </strong>
         , diagnosed by biochemical and molecular genetic testing, in cases of stroke with painful neuropathy. (See
         <a class="medical medical_review" href="/z/d/html/7195.html" rel="external">
          "Fabry disease: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6194.html" rel="external">
          "Fabry disease: Neurologic manifestations"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Connective tissue disorders
         </strong>
         , in cases of hyperextensibility and dissection. Considerations include Ehlers-Danlos type IV disease, with genetic testing for
         <em>
          COL3A1
         </em>
         mutations, and Loeys-Dietz syndrome, with genetic testing for
         <em>
          TGFBR1
         </em>
         ,
         <em>
          TGFBR2
         </em>
         , and
         <em>
          SMAD3
         </em>
         mutations. Alternatively, a gene panel for connective tissue disorders may be obtained. (See
         <a class="medical medical_review" href="/z/d/html/14920.html" rel="external">
          "Clinical manifestations and diagnosis of Ehlers-Danlos syndromes", section on 'Vascular EDS'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8150.html" rel="external">
          "Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders", section on 'TGFBR1 or TGFBR2 mutation: Loeys-Dietz syndrome'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          PHACE
         </strong>
         (syndrome of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities); the evaluation should include ophthalmology and dermatology consultations. The diagnosis can be made based upon the presence of a facial hemangioma greater than 5 cm in diameter plus one major or two minor criteria  (
         <a class="graphic graphic_table graphicRef110054" href="/z/d/graphic/110054.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/13735.html" rel="external">
          "PHACE syndrome", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mitochondrial disorders
         </strong>
         should be suspected when ischemic stroke does not conform to vascular territories.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          MELAS
         </strong>
         – The stroke-like episodes that occur in patients with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) are characterized by the acute onset of neurologic symptoms and high signal on diffusion-weighted MRI brain imaging. These episodes are different from typical embolic or thrombotic ischemic strokes:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         The brain lesions typically do not respect vascular territories
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         The apparent diffusion coefficient on MRI is not always decreased (as it would be with tissue infarction) but may be increased or demonstrate a mixed pattern
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         The acute MRI signal changes are not static and may migrate, fluctuate, or resolve more quickly and more often than would occur in a typical ischemic stroke
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         MELAS is discussed in greater detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5151.html" rel="external">
          "Mitochondrial myopathies: Clinical features and diagnosis", section on 'MELAS'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         When MELAS is suspected, the evaluation includes lactate levels from serum and cerebrospinal fluid, molecular genetic testing (of blood leukocytes, cultured skin fibroblast, skeletal muscle, urine sediment, and/or cheek mucosa), and muscle biopsy, particularly if genetic testing is nondiagnostic. These studies are not always abnormal in patients with MELAS because of heteroplasmy for mitochondrial mutations. (See
         <a class="medical medical_review" href="/z/d/html/5148.html" rel="external">
          "Mitochondrial regulation and functions", section on 'Heteroplasmy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          POLG-related disorders
         </strong>
         – Mutations in the
         <em>
          POLG1
         </em>
         gene are a rare cause of childhood stroke or stroke-like episodes with predominant involvement of the occipital lobes [
         <a href="#rid7">
          7,64,65
         </a>
         ]. Seizures, status epilepticus, and liver dysfunction or failure are frequently reported among children affected by stroke. The diagnosis is made by molecular genetic testing for
         <em>
          POLG
         </em>
         mutations.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H588039394">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112685.html" rel="external">
          "Society guideline links: Stroke in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Infants and young children
         </strong>
         – Infants and young children with stroke may present with focal weakness but are more likely than older children to present with seizures and altered mental status.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Older children
         </strong>
         – Older children usually have hemiparesis or other focal neurologic signs such as aphasia, visual disturbance, or cerebellar signs. However, seizures, headache, and lethargy are more common among children with stroke compared with adults. (See
         <a class="local">
          'Clinical presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Urgent evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Goals
         </strong>
         – The urgent evaluation starts with confirmation of the diagnosis of ischemic stroke (excluding hemorrhage and stroke mimics) and consideration of immediate interventions that may improve stroke outcome  (
         <a class="graphic graphic_algorithm graphicRef103189" href="/z/d/graphic/103189.html" rel="external">
          algorithm 1
         </a>
         ), including possible hyperacute reperfusion therapies with intravenous thrombolysis (within 4.5 hours of the time the patient was last seen well) and mechanical thrombectomy (within 24 hours of last seen well). (See
         <a class="local">
          'Goals of initial evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Hyperacute reperfusion therapies in children are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6215.html" rel="external">
          "Ischemic stroke in children: Management and prognosis", section on 'Reperfusion with thrombolysis and thrombectomy'
         </a>
         .).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Brain and vessel imaging
         </strong>
         – We suggest magnetic resonance imaging (MRI) of the brain with diffusion weighted imaging and vascular imaging with magnetic resonance angiography (MRA) as the initial studies, which should be obtained as soon as possible for children who present with suspected ischemic stroke. Head computed tomography (CT), including CT angiography (CTA), should be obtained if MRI and MRA are not tolerated or will not be available within one hour after arrival. (See
         <a class="local">
          'Brain imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Laboratories
         </strong>
         – In all patients, we obtain complete blood count, electrolytes, urea nitrogen, creatinine, serum glucose, prothrombin time (PT) and international normalized ratio (INR), partial thromboplastin time (PTT), and oxygen saturation. Additional studies in selected patients include hemoglobin electrophoresis and toxicology screen. (See
         <a class="local">
          'Laboratory studies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiologic evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          All patients
         </strong>
         – Evaluation of children with arterial ischemic stroke should screen for the most common causes, including imaging of intracranial and extracranial cerebral arteries (if not already done as part of the urgent evaluation), assessment of heart structure and function, hypercoagulable testing, and evaluation of inflammatory markers. (See
         <a class="local">
          'Essential evaluation for all patients'
         </a>
         above and
         <a class="local">
          'Cardiac evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Selected patients
         </strong>
         – For children with vasculopathy or those with no identified cause of arterial ischemic stroke, additional studies may be indicated to further characterize the underlying etiology. (See
         <a class="local">
          'Evaluation for etiology'
         </a>
         above and
         <a class="local">
          'Additional evaluation for selected patients'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – Numerous other conditions can present with acute neurologic deficits. Hemorrhagic stroke can mimic ischemic stroke and is best differentiated by neuroimaging. Nonvascular conditions that mimic stroke in children include tumors and other structural brain lesions, seizures with prolonged postictal paresis (Todd), and other conditions. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Zimmer JA, Garg BP, Williams LS, Golomb MR. Age-related variation in presenting signs of childhood arterial ischemic stroke. Pediatr Neurol 2007; 37:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mallick AA, Ganesan V, Kirkham FJ, et al. Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol 2014; 13:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chadehumbe MA, Khatri P, Khoury JC, et al. Seizures are common in the acute setting of childhood stroke: a population-based study. J Child Neurol 2009; 24:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abend NS, Beslow LA, Smith SE, et al. Seizures as a presenting symptom of acute arterial ischemic stroke in childhood. J Pediatr 2011; 159:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yock-Corrales A, Mackay MT, Mosley I, et al. Acute childhood arterial ischemic and hemorrhagic stroke in the emergency department. Ann Emerg Med 2011; 58:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           deVeber GA, Kirton A, Booth FA, et al. Epidemiology and Outcomes of Arterial Ischemic Stroke in Children: The Canadian Pediatric Ischemic Stroke Registry. Pediatr Neurol 2017; 69:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferriero DM, Fullerton HJ, Bernard TJ, et al. Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. Stroke 2019; 50:e51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asakai H, Cardamone M, Hutchinson D, et al. Arterial ischemic stroke in children with cardiac disease. Neurology 2015; 85:2053.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng HH, Rajagopal S, McDavitt E, et al. Stroke in Acquired and Congenital Heart Disease Patients and Its Relationship to Hospital Mortality and Lasting Neurologic Deficits. Pediatr Crit Care Med 2016; 17:976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dowling MM, Hynan LS, Lo W, et al. International Paediatric Stroke Study: stroke associated with cardiac disorders. Int J Stroke 2013; 8 Suppl A100:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziesmann MT, Nash M, Booth FA, Rafay MF. Cardioembolic stroke in children: a clinical presentation and outcome study. Pediatr Neurol 2014; 51:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCrea N, Saunders D, Bagkeris E, et al. Diagnosis of vertebral artery dissection in childhood posterior circulation arterial ischaemic stroke. Dev Med Child Neurol 2016; 58:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rollins N, Pride GL, Plumb PA, Dowling MM. Brainstem strokes in children: an 11-year series from a tertiary pediatric center. Pediatr Neurol 2013; 49:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mackay MT, Prabhu SP, Coleman L. Childhood posterior circulation arterial ischemic stroke. Stroke 2010; 41:2201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fink M, Slavova N, Grunt S, et al. Posterior Arterial Ischemic Stroke in Childhood. Stroke 2019; 50:2329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goeggel Simonetti B, Rafay MF, Chung M, et al. Comparative study of posterior and anterior circulation stroke in childhood: Results from the International Pediatric Stroke Study. Neurology 2020; 94:e337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shellhaas RA, Smith SE, O'Tool E, et al. Mimics of childhood stroke: characteristics of a prospective cohort. Pediatrics 2006; 118:704.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mackay MT, Yock-Corrales A, Churilov L, et al. Differentiating Childhood Stroke From Mimics in the Emergency Department. Stroke 2016; 47:2476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braun KP, Kappelle LJ, Kirkham FJ, Deveber G. Diagnostic pitfalls in paediatric ischaemic stroke. Dev Med Child Neurol 2006; 48:985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mackay MT, Monagle P, Babl FE. Improving diagnosis of childhood arterial ischaemic stroke. Expert Rev Neurother 2017; 17:1157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rafay MF, Pontigon AM, Chiang J, et al. Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke 2009; 40:58.
          </a>
         </li>
         <li class="breakAll">
          Stroke in childhood: Clinical guideline for diagnosis, management and rehabilitation (2017). Royal College of Paediatrics and Child Health. http://www.rcpch.ac.uk/stroke-guideline (Accessed on April 18, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elbers J, Wainwright MS, Amlie-Lefond C. The Pediatric Stroke Code: Early Management of the Child with Stroke. J Pediatr 2015; 167:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mallick AA, Ganesan V, Kirkham FJ, et al. Diagnostic delays in paediatric stroke. J Neurol Neurosurg Psychiatry 2015; 86:917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernard TJ, Friedman NR, Stence NV, et al. Preparing for a "Pediatric Stroke Alert". Pediatr Neurol 2016; 56:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mirsky DM, Beslow LA, Amlie-Lefond C, et al. Pathways for Neuroimaging of Childhood Stroke. Pediatr Neurol 2017; 69:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christy A, Murchison C, Wilson JL. Quick Brain Magnetic Resonance Imaging With Diffusion-Weighted Imaging as a First Imaging Modality in Pediatric Stroke. Pediatr Neurol 2018; 78:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Medley TL, Miteff C, Andrews I, et al. Australian Clinical Consensus Guideline: The diagnosis and acute management of childhood stroke. Int J Stroke 2019; 14:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beslow LA, Smith SE, Vossough A, et al. Hemorrhagic transformation of childhood arterial ischemic stroke. Stroke 2011; 42:941.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hutchinson ML, Beslow LA. Hemorrhagic Transformation of Arterial Ischemic and Venous Stroke in Children. Pediatr Neurol 2019; 95:26.
          </a>
         </li>
         <li class="breakAll">
          Barkovich A. Pediatric Neuroimaging, Lippincott-Raven, Philadelphia 2000.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdelhalim AN, Alberico RA. Pediatric neuroimaging. Neurol Clin 2009; 27:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ketonen LM, Valanne L. Neuroimaging of pediatric diseases. Semin Neurol 2008; 28:558.
          </a>
         </li>
         <li class="breakAll">
          Fundamentals of Diagnostic Radiology, 2nd, Brant WE, Helms CA (Eds), Lippincott Williams &amp; Wilkins, Philadlphia 1999.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopkins KL, Davis PC, Sanders CL, Churchill LH. Sedation for pediatric imaging studies. Neuroimaging Clin N Am 1999; 9:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donnelly LF, Emery KH, Brody AS, et al. Minimizing radiation dose for pediatric body applications of single-detector helical CT: strategies at a large Children's Hospital. AJR Am J Roentgenol 2001; 176:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seemanová E, Jarolím P, Seeman P, et al. [Increased risk of malignancies in heterozygotes in families of patients with Nijmegen breakage syndrome]. Cas Lek Cesk 2006; 145:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 2001; 176:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mehyar LS, Abu-Arja MH, Stanek JR, et al. The Risk of Developing Secondary Central Nervous System Tumors After Diagnostic Irradiation From Computed Tomography in Pediatrics: A Literature Review. Pediatr Neurol 2019; 98:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meulepas JM, Ronckers CM, Smets AMJB, et al. Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands. J Natl Cancer Inst 2019; 111:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall P, Adami HO, Trichopoulos D, et al. Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ 2004; 328:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffiths PD, Morrison GD. Computed tomography in children. BMJ 2004; 329:930.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donnelly LF. Reducing radiation dose associated with pediatric CT by decreasing unnecessary examinations. AJR Am J Roentgenol 2005; 184:655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brody AS, Frush DP, Huda W, et al. Radiation risk to children from computed tomography. Pediatrics 2007; 120:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah NB, Platt SL. ALARA: is there a cause for alarm? Reducing radiation risks from computed tomography scanning in children. Curr Opin Pediatr 2008; 20:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yabuuchi H, Kamitani T, Sagiyama K, et al. Clinical application of radiation dose reduction for head and neck CT. Eur J Radiol 2018; 107:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goske MJ, Applegate KE, Boylan J, et al. The Image Gently campaign: working together to change practice. AJR Am J Roentgenol 2008; 190:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee S, Heit JJ, Albers GW, et al. Neuroimaging selection for thrombectomy in pediatric stroke: a single-center experience. J Neurointerv Surg 2019; 11:940.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wintermark M, Lepori D, Cotting J, et al. Brain perfusion in children: evolution with age assessed by quantitative perfusion computed tomography. Pediatrics 2004; 113:1642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kansagra S, Mikati MA, Vigevano F. Alternating hemiplegia of childhood. Handb Clin Neurol 2013; 112:821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lanthier S, Carmant L, David M, et al. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000; 54:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sträter R, Vielhaber H, Kassenböhmer R, et al. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999; 158 Suppl 3:S122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wintermark M, Hills NK, DeVeber GA, et al. Clinical and Imaging Characteristics of Arteriopathy Subtypes in Children with Arterial Ischemic Stroke: Results of the VIPS Study. AJNR Am J Neuroradiol 2017; 38:2172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindenholz A, van der Kolk AG, Zwanenburg JJM, Hendrikse J. The Use and Pitfalls of Intracranial Vessel Wall Imaging: How We Do It. Radiology 2018; 286:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mandell DM, Mossa-Basha M, Qiao Y, et al. Intracranial Vessel Wall MRI: Principles and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol 2017; 38:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dlamini N, Yau I, Muthusami P, et al. Arterial Wall Imaging in Pediatric Stroke. Stroke 2018; 49:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rumsey DG, Myones B, Massicotte P. Diagnosis and treatment of antiphospholipid syndrome in childhood: A review. Blood Cells Mol Dis 2017; 67:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caorsi R, Penco F, Grossi A, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis 2017; 76:1648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 2014; 370:911.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee PY. Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2. Front Pediatr 2018; 6:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regalado ES, Mellor-Crummey L, De Backer J, et al. Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations. Genet Med 2018; 20:1206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Arco F, Alves CA, Raybaud C, et al. Expanding the Distinctive Neuroimaging Phenotype of ACTA2 Mutations. AJNR Am J Neuroradiol 2018; 39:2126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brinjikji W, Swanson JW, Zabel C, et al. Stroke and Stroke-Like Symptoms in Patients with Mutations in the POLG1 Gene. JIMD Rep 2011; 1:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheldi A, Ronchi D, Bordoni A, et al. POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome. BMC Neurol 2013; 13:8.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6214 Version 44.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17765804" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Age-related variation in presenting signs of childhood arterial ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24304598" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18923086" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Seizures are common in the acute setting of childhood stroke: a population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21429519" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Seizures as a presenting symptom of acute arterial ischemic stroke in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21310508" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Acute childhood arterial ischemic and hemorrhagic stroke in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28254555" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology and Outcomes of Arterial Ischemic Stroke in Children: The Canadian Pediatric Ischemic Stroke Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30686119" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26408496" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Arterial ischemic stroke in children with cardiac disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27509364" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Stroke in Acquired and Congenital Heart Disease Patients and Its Relationship to Hospital Mortality and Lasting Neurologic Deficits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23231361" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : International Paediatric Stroke Study: stroke associated with cardiac disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25266612" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Cardioembolic stroke in children: a clinical presentation and outcome study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26502795" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Diagnosis of vertebral artery dissection in childhood posterior circulation arterial ischaemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24080274" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Brainstem strokes in children: an 11-year series from a tertiary pediatric center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20829517" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Childhood posterior circulation arterial ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31345132" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Posterior Arterial Ischemic Stroke in Childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31857436" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Comparative study of posterior and anterior circulation stroke in childhood: Results from the International Pediatric Stroke Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16882826" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Mimics of childhood stroke: characteristics of a prospective cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27601378" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Differentiating Childhood Stroke From Mimics in the Emergency Department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17109788" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Diagnostic pitfalls in paediatric ischaemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29057682" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Improving diagnosis of childhood arterial ischaemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18802206" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Delay to diagnosis in acute pediatric arterial ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18802206" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Delay to diagnosis in acute pediatric arterial ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25937428" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The Pediatric Stroke Code: Early Management of the Child with Stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25342203" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Diagnostic delays in paediatric stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26969238" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Preparing for a "Pediatric Stroke Alert".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28274641" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Pathways for Neuroimaging of Childhood Stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29174005" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Quick Brain Magnetic Resonance Imaging With Diffusion-Weighted Imaging as a First Imaging Modality in Pediatric Stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30284961" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Australian Clinical Consensus Guideline: The diagnosis and acute management of childhood stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21350202" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Hemorrhagic transformation of childhood arterial ischemic stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30904397" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Hemorrhagic Transformation of Arterial Ischemic and Venous Stroke in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30904397" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Hemorrhagic Transformation of Arterial Ischemic and Venous Stroke in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19055984" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Pediatric neuroimaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18843582" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Neuroimaging of pediatric diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18843582" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Neuroimaging of pediatric diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9974495" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Sedation for pediatric imaging studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11159061" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Minimizing radiation dose for pediatric body applications of single-detector helical CT: strategies at a large Children's Hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16521404" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : [Increased risk of malignancies in heterozygotes in families of patients with Nijmegen breakage syndrome].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11159059" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Estimated risks of radiation-induced fatal cancer from pediatric CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22681860" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31235364" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The Risk of Developing Secondary Central Nervous System Tumors After Diagnostic Irradiation From Computed Tomography in Pediatrics: A Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30020493" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14703539" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15499088" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Computed tomography in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15671393" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Reducing radiation dose associated with pediatric CT by decreasing unnecessary examinations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766543" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Radiation risk to children from computed tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18475090" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : ALARA: is there a cause for alarm? Reducing radiation risks from computed tomography scanning in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30177405" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Clinical application of radiation dose reduction for head and neck CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18212208" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The Image Gently campaign: working together to change practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31097548" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Neuroimaging selection for thrombectomy in pediatric stroke: a single-center experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15173485" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Brain perfusion in children: evolution with age assessed by quantitative perfusion computed tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23622289" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Alternating hemiplegia of childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10668698" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Stroke in children: the coexistence of multiple risk factors predicts poor outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10650850" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28982784" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Clinical and Imaging Characteristics of Arteriopathy Subtypes in Children with Arterial Ischemic Stroke: Results of the VIPS Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29261469" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The Use and Pitfalls of Intracranial Vessel Wall Imaging: How We Do It.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27469212" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Intracranial Vessel Wall MRI: Principles and Expert Consensus Recommendations of the American Society of Neuroradiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29581340" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Arterial Wall Imaging in Pediatric Stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28283251" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Diagnosis and treatment of antiphospholipid syndrome in childhood: A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28522451" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24552284" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Early-onset stroke and vasculopathy associated with mutations in ADA2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30406060" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29300374" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30262641" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Expanding the Distinctive Neuroimaging Phenotype of ACTA2 Mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23430834" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Stroke and Stroke-Like Symptoms in Patients with Mutations in the POLG1 Gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23324391" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
